A new study being published in the Sept. 15 issue of Biological Psychiatry reports that genetic variation in a particular enzyme affects the success rates of treatment with bupropion, an antismoking drug.
The National Kidney Disease Education Program (NKDEP), an initiative of the National Institutes of Health (NIH), has created an educational brochure tailored specifically for African Americans at risk for kidney disease.
In the year since it was established, the international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40%, and those for second-line antiretroviral (ARV) drugs by between 25% and 50%.
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
Giving a daily antiretroviral pill to people to prevent HIV could profoundly slow the spread of the infection in sub-Saharan Africa, where it is a full-blown epidemic, University of Pittsburgh School of Medicine researchers report.
Gynecomastia, the benign enlargement of male breast tissue, is a common occurrence in adolescents as well as in middle-aged and older men. While there are several reasons why men develop breast tissue, it is usually not a health concern, often resolves on its own, and is generally treatable, according to a clinical practice article appearing in the September 20 issue of the New England Journal of Medicine (NEJM).
Lupus occurs when the immune system misfires and attacks the body’s organs and tissues. Nobody knows exactly why this happens, but a new study points to one possible cause.
Anna Cataldi, who served as UN Messenger of Peace from 1998 to 2007, has joined the global fight against tuberculosis (TB). Ms Cataldi, who was today appointed as an Ambassador of the Stop TB Partnership, will raise awareness worldwide about the unfair burden of TB on refugees, migrants, people living in poverty and other disadvantaged groups.
The Bill & Melinda Gates Foundation announced grants totaling $280 million to help fight tuberculosis, an epidemic that infects one-third of people on earth and kills nearly 2 million yearly—mostly in the poorest countries.
Patients who received hemodialysis at night six times a week for treatment of end-stage kidney disease had improvements on certain outcomes, including reduced need for blood pressure medications and improvement in selected quality of life measures, compared to patients who received conventional hemodialysis three times weekly, according to an article in the September 19 issue of JAMA.